Last updated on June 2017

Real-World Evaluation Screening Study and Registry of Dyskinesia in Patients Taking Antipsychotic Agents


Brief description of study

Real-World Evaluation Screening Study and Registry of Dyskinesia in Patients Taking Antipsychotic Agents

Detailed Study Description

Prospective study to quantify the prevalence of possible tardive dyskinesia (TD) in outpatient psychiatry practices in the United States (US), as well as to describe the associated disease burden in a cohort of patients with one or more psychiatric disorders and a cumulative lifetime exposure to antipsychotic medication of three months or more

Clinical Study Identifier: TX149983

Find a site near you

Start Over

APG Research, LLC

721 N.Magnolia Avenue Orlando, FL USA
  Connect »